Agrochemicals

Agricultural practices are under huge scrutiny: environmental concerns, issues of sustainability, security and reliability interplay with commercial aspects relating to the cost and the quality of agricultural products, be they plants or livestock. Historically, agrochemicals have featured prominently in the development of new and improved methods of agronomy and animal husbandry. The opportunities within these areas of agriculture are vast, and offer exciting prospects for those working in both the chemical and life sciences fields. Novel technologies proving clear agricultural benefits are deserving of protection, and Mewburn Ellis can provide the bespoke advice and support for those looking to secure a strong commercial position in a frequently highly competitive area.

Agrochemicals are wide-ranging in their use, their activity and fundamentally in their structures also. Mewburn Ellis can provide a strength and depth of intellectual property experience that is unrivalled, and is well matched to the challenges in this technology. We have a strong, personal interest in animal and plant health and the environmental benefits that arise from a close control of pests and diseases, closely aligned with biosafety concerns. Many agricultural technology firms now place environmental protection at the forefront of their research work and this aligns with our own values and ethos, and we are proud to work for clients who promote and develop sustainably agriculture around the world.

We can provide the critical assessment of the experiments that support the latest agrochemical innovations, and we appreciate the difficulties in obtaining data from complex biological models and extensive field trials. Indeed, we are also regularly work with our clients to design those experiments and to select comparisons that will show an invention to its greatest advantage. We look to exploit good data, and use it as the basis for strong, defendable patents. Our hard work from the very start of the research and development process gives our clients the reward of strong - frequently foundational – intellectual property with clear commercial relevance. Our interest in the larger relevance of the technology to its exploitation also provides us with the opportunity to clear the disrupting obstacles placed by competitors. Our work in opposing competitors’ patents in Europe is highly envied, and we can point to many significant examples where we have severely limited or entirely destroyed the patents of those attempting to limit the work of our clients.

We support innovation, and we are always attracted to agrochemical firms who marry forward thinking research work with a strong social responsibility. We can and will look to support those companies who encourage agronomy and livestock health with environmental sustainability.

Meet our Specialists

OUR PEOPLE
Open pages of Green IP Report

Green IP Report

Patents are both a driver and a barometer of innovation

Our report examines the role of patents in making innovative ‘green’ technologies into a reality as well as how the patent landscape can be used to identify opportunities for partnering, collaboration and investment.

We share our enthusiasm and admiration for commercially-focused innovation across a diverse range of technologies, from repurposing carbon dioxide to make protein-rich foods, to the multi-faceted approach to a circular plastics economy. We also discuss the tantalising prospect of AI-mediated renewable energy supply, and the harnessing of battery tech from the EV boom to drive energy efficiency in consumer devices. This report reflects our passion for technology solutions that tackle our shared global challenge.

Download the Report

Read our Blogs

Our clients are at the heart of our Trade Mark business

Our clients are at the heart of our Trade Mark business

We are delighted to release our latest brochure 'Our clients are at the heart of our Trade Mark business'.

UPC Weekly - Battling the Biosimilars: opt-outs, preliminary injunctions & protective letters

UPC Weekly - Battling the Biosimilars: opt-outs, preliminary injunctions & protective letters

2024 Week 17 This week we delve into the details of the first two UPC disputes involving biosimilars. Alexion Pharmaceuticals have launched UPC proceedings against Amgen and Samsung, while Novartis ...

Cleantech Commercialisation Report: Highlights and Trends

Cleantech Commercialisation Report: Highlights and Trends

Today (26 April 2024) the European Patent Office (EPO) and the European Investment Bank (EIB) published an in-depth (and very lengthy) report on financing and commercialisation of cleantech. [For ...

The brilliant dawn of AI drug discovery

The brilliant dawn of AI drug discovery

Computer simulations are solving challenges previously thought uncrackable.

Medical devices: Insights through IP - new report 2024

Medical devices: Insights through IP - new report 2024

We are delighted to release our latest report Medical devices: Insights through IP which looks at the recent IP trends in the medical devices sector.

UPC Weekly - Language of proceedings at the UPC

UPC Weekly - Language of proceedings at the UPC

2024 Week 16 This week we focus on the language of proceedings at the UPC, considering when the defendant can successfully request a change of the language of proceedings, and an overview of the ...

Learn More
Forward Magazines Overlapping 8

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.